Latest News in the pharma Industry

All

Fiasp - a new, ultra-fast acting mealtime insulin

Fiasp - a new, ultra-fast acting mealtime insulin

28 Mar 2017

Canada first country to launch Fiasp.

Read more 
Regeneron and Sanofi announce FDA approval of Dupixent

Regeneron and Sanofi announce FDA approval of Dupixent

28 Mar 2017

First targeted biologic therapy for adults with moderate-to-severe atopic dermatitis.

Read more 
Encouraging results of Phase IIa study with Evenamide in patients with schizophrenia

Encouraging results of Phase IIa study with Evenamide in patients with schizophrenia

27 Mar 2017

Unique mechanism: glutamate modulation and voltage-gated sodium channel blockade.

Read more 
Eprex marketing authorisation extended to include treatment of symptomatic anaemia

Eprex marketing authorisation extended to include treatment of symptomatic anaemia

27 Mar 2017

French Health Authority ANSM grants approval in the Mutual Recognition Procedure; the relevant health authorities are required to implement the new indication within 30 days.

Read more 
Pfizer receives positive CHMP opinion for Trumenba for prevention of meningococcal group B disease

Pfizer receives positive CHMP opinion for Trumenba for prevention of meningococcal group B disease

27 Mar 2017

Trumenba has been studied in a global clinical development program evaluating the vaccine in adolescents and adults.

Read more 
Invivotek completes solar farm and facility expansion

Invivotek completes solar farm and facility expansion

27 Mar 2017

Provides a cleaner, renewable energy source to reduce costs and lessen the CRO facility's impact on the environment.

Read more 
BMS receives positive CHMP opinion recommending Opdivo for head and neck cancer

BMS receives positive CHMP opinion recommending Opdivo for head and neck cancer

26 Mar 2017

Opdivo already approved by the EC for six indications in four distinct tumour types.

Read more 
FDA approves Parkinson's disease drug

FDA approves Parkinson's disease drug

24 Mar 2017

First NCE approved for PD patients with motor fluctuations in the US in more than a decade .

Read more 
Lilly to invest $850 million  in US capital projects in 2017

Lilly to invest $850 million in US capital projects in 2017

24 Mar 2017

Significant investment in manufacturing diabetes medicines continues with new $85 million commitment in Indianapolis.

Read more 
Cobra Biologics wins ‘CMO Leadership Award’ in five categories

Cobra Biologics wins ‘CMO Leadership Award’ in five categories

23 Mar 2017

More than 80 contract manufactures were assessed by 26 performance metrics in ISR’s annual Contract Manufacturing Quality Benchmarking survey.

Read more 
Aptar Pharma’s Preservative-Free Multidose Dispenser chosen for Restasis Multidose launch

Aptar Pharma’s Preservative-Free Multidose Dispenser chosen for Restasis Multidose launch

23 Mar 2017

Aptar Pharma’s Ophthalmic Squeeze Dispenser system is the result of more than 10 years of development and experience in the delivery of preservative-free ophthalmic solutions.

Read more 
Reig Jofre starts marketing of three new injectble products for hospitals

Reig Jofre starts marketing of three new injectble products for hospitals

23 Mar 2017

Developments correspond to generic products based on specialized pharmaceutical technologies.

Read more